BLFS Q2 2024 Earnings — BioLife Solutions, Inc. Revenue & Financial Results | Market Cap Arena

BLFSBioLife Solutions, Inc.

$921M

Q2 2024 Earnings

Healthcare Medical - Instruments & Supplies

Income Statement

Revenue

$20M-50.1% YoY

Gross Profit

$13M67.0% margin

Operating Income

-$4M-18.6% margin

Net Income

-$21M-105.1% margin

EPS (Diluted)

$-0.45

QoQ Revenue Growth

+7.0%

Cash Flow

Operating Cash Flow

$6M

Free Cash Flow

$5M

Stock-Based Comp.

$9M

Balance Sheet

Total Assets

$375M

Total Liabilities

$54M

Stockholders' Equity

$321M

Cash & Equivalents

$22M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$20M	$40M	-50.1%
Gross Profit	$13M	$12M	+11.8%
Operating Income	-$4M	-$15M	+76.0%
Net Income	-$21M	-$10M	-103.1%

Revenue Segments

Product

$21M41%

Product, Cell Processing

$18M34%

Rental Revenue

$5M10%

Service

$4M8%

Product, Freezer and Thaw

$3M6%